Utility of Baseline Assessment With FDG-PET-CT Compared With CT Scanning in People With Diffuse Large B-Cell Lymphoma (DLBCL)

Hematological Oncology - United Kingdom
doi 10.1002/hon.2439_38
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Diagnostic and Prognostic Value of Baseline FDG PET/CT Skeletal Textural Features in Diffuse Large B Cell Lymphoma

European Journal of Nuclear Medicine and Molecular Imaging
MedicineNuclear MedicineRadiologyImaging
2017English

Outcome After Salvage Radiotherapy to FDG-Pet/Ct Avid Disease Post Chemotherapy in Advanced Stage Diffuse Large B-Cell Lymphoma (Dlbcl)

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Prognostic Value of Baseline FDG Pet Parameters in High Risk Diffuse Large B-Cell Lymphoma Patients

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Metabolic Heterogeneity of Baseline 18-FDG Pet-Ct Scan Predicts Outcome in Primary Mediastinal B-Cell Lymphoma.

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Simultaneous Breast Cancer and DLBCL Lymphoma — Role of PET/CT Examination With 18f-FDG and 18f-Fes

Nuclear Medicine Review
MedicineNuclear MedicineRadiologyImaging
2018English

Antiviral Therapy and Immunochemotherapy in Patients With Diffuse Large B-Cell Lymphoma (Dlbcl) With Hepatitis C (Hcv)

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

PET/CT Scanner and Bone Marrow Biopsy in Detection of Bone Marrow Involvement in Diffuse Large B-Cell Lymphoma

PLoS ONE
Multidisciplinary
2017English

Predictive Potential of FDG-PET/CT for Histological Transformation in Patients With Indolent Lymphoma

Advances in Molecular Imaging
2014English

Prognostic Value of Diffuse Splenic FDG Uptake on PET/CT in Patients With Gastric Cancer

PLoS ONE
Multidisciplinary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy